Startups
Our unique technology platform and expertise accelerate outcomes generation and regulatory reviews for health products. Our HIVE platform is the sole bioinformatics platform used by the FDA for its regulatory evaluation of genomic data and analytical pipelines as part of new precision medicine drug and companion diagnostic approvals, HIVE manages over 15 petabytes of data and contains unique bioinformatics algorithms and pipelines built to power more than 100 regulatory reviews at the FDA in the areas of immuno-oncology, cell therapies, vaccines, anti-virals and other precision medicine therapeutic areas. Combined with HIVE, our Virtual Studies technology is used by more than 2,000 active patients every day to collect, curate and generate regulatory-grade data and powers Real-World Data (RWD) platforms for the Epilepsy Foundation, Multiple Sclerosis Association of America, life sciences companies such as Galderma, and 15 care and research centers such as NYU Langone, George Washington University, UCSF, Yale, Mayo Clinic, Georgetown University and others.
Overview
Location
United States, New York
Employees
11-50
Total raised
$3.7M
Founded date
2017
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 15
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 17, 2021 | Startups at CES showed how tech can help elderly people and their caregivers | The COVID-19 pandemic shined a harsh spotlight on the challenges many elderly people face. Older adults are among the highest-risk groups for developing cases that need hospitalization and nursing homes were especially vulnerable to outbrea... |
| Dec 18, 2019 | MassChallenge announces its startup class of 2020 | |
| Dec 17, 2019 | MassChallenge HealthTech Announces 2020 Cohort of Top Digital Health Startups | December 18, 2019 (Boston) - MassChallenge, a global network of zero-equity startup accelerators, today announced that 27 digital health startups will join the 2020 MassChallenge HealthTech cohort. The 27 startups represent some of the worl... |
| Apr 10, 2019 | Embleema teams up with Armenian government on healthcare blockchain effort | Embleema Blockchain Consortium head Alexis Normand said in a statement that potential benefits from the partnership include offering physicians better access to health data and connecting Armenia to international research, especially in onc... |
| Feb 7, 2019 | Term Sheet — Thursday, February 7 | 5 Qs WITH A DEALMAKER Good morning, Term Sheet readers. Paid Content Securing the enterprise without boundaries From ExtraHop E-scooter startup Lime announced yesterday that it has raised a whopping $310 million in Series D funding at a $2.... |
| Feb 6, 2019 | Healthcare Blockchain Developer Embleema Nabs $3.7M to Develop Blockchain Apps for Patients | Healthcare-blockchain developer, Embleema has raised $3.7M in Series A funding round, led by strategic partner Pharmagest, a leading pharmacy software group in Europe, and Techstars. The funds will serve to accelerate the joint development ... |
| Feb 6, 2019 | Embleema Closes $3.7M Series A Funding | NEW YORK, NY, Leader in blockchain for health, announced today that it has closed a $3.7M Series A funding round, led by strategic partner Pharmagest. >> Click here for more funding data on Embleema >> To export Embleema fun... |
| Feb 6, 2019 | Embleema Closes $3.7M Series A Funding Round | Embleema, a Metuchen NJ and Paris, France-based startup advancing blockchain for health, closed a $3.7M Series A funding. The round was led by strategic partner Pharmagest and Techstars. The company intends to use the funds to accelerate th... |
| Feb 6, 2019 | Embleema Closes $3.7M Series A Funding Round | NEW YORK & PARIS--(BUSINESS WIRE)--Embleema, the leader in blockchain for health, announced today that it has closed a $3.7M Series A funding round, led by strategic partner Pharmagest, a leading pharmacy software group in Europe, and T... |
Show more
Reviews 0
FAQ about Embleema
When was Embleema founded?
Embleema was founded in 2017.
How much funding has Embleema raised?
Embleema has raised $3.7M in total across 1 funding round.
What has the press written about Embleema?
Parsers VC has collected 15 articles mentioning Embleema, among them “Startups at CES showed how tech can help elderly people and their caregivers” (Jan 17, 2021) and “MassChallenge announces its startup class of 2020” (Dec 18, 2019).
Is Embleema still active?
Yes, Embleema is active; its latest activity on Parsers VC dates from Dec 7, 2022.